Interestingly, when OSA CD4+ T-cells were treated with αPSGL-1 antibody this effect was reverted (Figure 3A), indicating that T-cell proliferation impairment in OSA patients may be mediated by PSGL-1. The gene discussed is CD4; the disease is obstructive sleep apnea syndrome.